Lisanti Capital Growth, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 156 filers reported holding CARDLYTICS INC in Q4 2019. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2021$3,354,000
-48.6%
26,425
-55.5%
0.42%
-50.4%
Q1 2021$6,519,000
-29.8%
59,425
-8.7%
0.84%
-35.0%
Q4 2020$9,292,000
+354.4%
65,085
+124.5%
1.29%
+239.3%
Q3 2020$2,045,000
-55.4%
28,985
-55.8%
0.38%
-59.5%
Q2 2020$4,586,000
+536.1%
65,535
+217.8%
0.94%
+292.9%
Q1 2020$721,000
-66.4%
20,620
-39.6%
0.24%
-58.2%
Q4 2019$2,145,00034,1300.57%
Other shareholders
CARDLYTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders